SCHEMBL3350429

SCHEMBL3350429

Cc1nc2ccc(Cl)cc2c(-c2ccccc2)c1CC=O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.70
FABP4 P15090 5/20 0.60
FABP3 P05413 4/20 0.60
PLA2G2A P14555 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.51
LMNA P02545 2/20 0.51
FABP5 Q01469 4/20 0.50
HTT P42858 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
DHODH Q02127 1/20 0.43
MAPK1 P28482 1/20 0.42
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
PRNP P04156 1/20 0.41
PPARG P37231 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
NR2E3 Q9Y5X4 1/20 0.41
NCOR2 Q9Y618 1/20 0.41
MAT2A P31153 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5177389 0.87 KDM4E (0.52) KDM4EFABP4FABP3SMN1; SMN2LMNA
SCHEMBL5177676 0.86 SMN1; SMN2 (0.54) KDM4EFABP4FABP3PLA2G2ASMN1; SMN2
SCHEMBL5178272 0.85 RXFP1 (0.60) KDM4EFABP4FABP3SMN1; SMN2HTT
SCHEMBL28661629 0.84 SMN1; SMN2 (0.65) KDM4ESMN1; SMN2LMNAMAPK1MAPT
SCHEMBL31442473 0.82 KDM4E (0.49) KDM4EFABP4FABP3PLA2G2ASMN1; SMN2
SCHEMBL3346066 0.81 KDM4E (0.71) KDM4EFABP4FABP3PLA2G2ASMN1; SMN2
SCHEMBL5178406 0.79 KDM4E (0.47) KDM4EPLA2G2ASMN1; SMN2LMNADHODH
SCHEMBL5178029 0.79 DHODH (0.48) KDM4EFABP4FABP3PLA2G2ASMN1; SMN2
SCHEMBL5177281 0.79 KDM4E (0.47) KDM4EFABP4FABP3PLA2G2ASMN1; SMN2
SCHEMBL27703988 0.76 FABP4 (0.58) KDM4EFABP4FABP3PLA2G2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1809605-A1 QUINOLINE AS ALLOSTERIC ENHANCERS OF THE GABA-B RECEPTORS F. Hoffmann-Roche AG (CH) 2007-07-25 EP claimed
WO-2006048146-A1 QUINOLINE AS ALLOSTERIC ENHANCERS OF THE GABA-B RECEPTORS F. HOFFMANN-LA ROCHE AG (CH) 2006-05-11 WO claimed
WO-2010056865-A1 QUINOLINE DERIVATIVES AS ION CHANNEL MODULATORS GILEAD PALO ALTO, INC. (US) 2010-05-20 WO disclosed
EP-1809605-A1 QUINOLINE AS ALLOSTERIC ENHANCERS OF THE GABA-B RECEPTORS F. Hoffmann-Roche AG (CH) 2007-07-25 EP disclosed
WO-2006048146-A1 QUINOLINE AS ALLOSTERIC ENHANCERS OF THE GABA-B RECEPTORS F. HOFFMANN-LA ROCHE AG (CH) 2006-05-11 WO disclosed